Robert-Jan van Geuns mainly investigates Internal medicine, Cardiology, Radiology, Coronary artery disease and Myocardial infarction. His research on Internal medicine often connects related areas such as Surgery. His Cardiology research incorporates elements of Confidence interval, Hazard ratio and Clinical endpoint.
His Radiology research includes themes of Electrocardiography, Coronary arteries and Everolimus. His Coronary artery disease research is multidisciplinary, relying on both Conventional PCI, Acute coronary syndrome, Intravascular ultrasound, Fractional flow reserve and Angiography. His Myocardial infarction research focuses on subjects like Restenosis, which are linked to Thrombosis, Lumen and Target lesion.
His primary scientific interests are in Internal medicine, Cardiology, Percutaneous coronary intervention, Coronary artery disease and Radiology. His Internal medicine study frequently draws connections between related disciplines such as Surgery. His work carried out in the field of Cardiology brings together such families of science as Magnetic resonance imaging and Hazard ratio.
As a part of the same scientific study, Robert-Jan van Geuns usually deals with the Percutaneous coronary intervention, concentrating on Conventional PCI and frequently concerns with Confidence interval. His research integrates issues of Lesion, Cardiovascular agent, Revascularization, Thrombosis and Prospective cohort study in his study of Coronary artery disease. His Radiology study incorporates themes from Coronary angiography, Coronary arteries and Nuclear medicine.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Percutaneous coronary intervention, Coronary artery disease and Conventional PCI. Myocardial infarction, Clinical endpoint, Acute coronary syndrome, Hazard ratio and Intravascular ultrasound are the core of his Internal medicine study. His biological study spans a wide range of topics, including Prospective cohort study and Magnetic resonance imaging.
The study incorporates disciplines such as Stroke, Stent and Coronary stent in addition to Percutaneous coronary intervention. His Stent research is included under the broader classification of Surgery. His research in Coronary artery disease intersects with topics in Lesion, Culprit, Coronary arteries, Radiology and Thrombosis.
His main research concerns Internal medicine, Cardiology, Coronary artery disease, Percutaneous coronary intervention and Conventional PCI. All of his Internal medicine and Myocardial infarction, Intravascular ultrasound, Prospective cohort study, Revascularization and Predictive value of tests investigations are sub-components of the entire Internal medicine study. His Cardiology research includes elements of Clinical endpoint and Hazard ratio.
Robert-Jan van Geuns has researched Coronary artery disease in several fields, including Fractional flow reserve, Radiology, Acute coronary syndrome and Mace. The various areas that he examines in his Percutaneous coronary intervention study include Survival analysis, Conditional survival and Cumulative survival. His study in Conventional PCI is interdisciplinary in nature, drawing from both Hemodynamics, Percutaneous, Randomized controlled trial and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Images in Cardiovascular Medicine
C.S. Breburda;Robert Jan van Geuns;Jos Bekkers;Maarten Janssen.
Circulation (Baltimore) (2000)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker;Patrick Serruys;Simon Wandel;Pawel Buszman.
The Lancet (2008)
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W Serruys;Sigmund Silber;Scot Garg;Robert Jan van Geuns.
The New England Journal of Medicine (2010)
Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.
Pieter C Smits;Robert-Jan M van Geuns;Don Poldermans;Manolis Bountioukos.
Journal of the American College of Cardiology (2003)
Evaluation of the Accuracy of Gadolinium-Enhanced Cardiovascular Magnetic Resonance in the Diagnosis of Cardiac Sarcoidosis
Jan-Peter Smedema;Gabriel Snoep;Marinus P.G. van Kroonenburgh;Robert-Jan van Geuns.
Journal of the American College of Cardiology (2005)
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabate;Angel Cequier;Andrés Iñiguez;Antonio Serra.
The Lancet (2012)
Usefulness of multislice computed tomography for detecting obstructive coronary artery disease
Koen Nieman;Benno J. Rensing;Robert-Jan M. van Geuns;Arie Munne.
American Journal of Cardiology (2002)
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm.
The Lancet (2018)
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study
Peter Barlis;Evelyn Regar;Patrick W. Serruys;Konstantinos Dimopoulos.
European Heart Journal (2010)
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
Patrick W. Serruys;Yoshinobu Onuma;Hector M. Garcia-Garcia;Takashi Muramatsu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: